Green Cross Holdings Preference Shares (KO:005257) — Market Cap & Net Worth
Market Cap & Net Worth: Green Cross Holdings Preference Shares (005257)
Green Cross Holdings Preference Shares (KO:005257) has a market capitalization of $2.29 Million (₩3.39 Billion) as of August 3, 2026. Listed on the KO stock exchange, this Korea-based company holds position #29830 globally and #2098 in its home market, demonstrating a -9.34% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Green Cross Holdings Preference Shares's stock price ₩14070.00 by its total outstanding shares 240657 (240.66K). See Green Cross Holdings Preference Shares capex to cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Green Cross Holdings Preference Shares Market Cap History: 2015 to 2026
Green Cross Holdings Preference Shares's market capitalization history from 2015 to 2026. Data shows change from $3.96 Million to $2.29 Million (-4.25% CAGR).
Green Cross Holdings Preference Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Green Cross Holdings Preference Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Green Cross Holdings Preference Shares's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.22 Million | $1.35 Trillion | $47.18 Billion | 0.00x | 0.00x |
| 2017 | $4.11 Million | $1.46 Trillion | $43.36 Billion | 0.00x | 0.00x |
| 2018 | $2.53 Million | $1.55 Trillion | $18.47 Billion | 0.00x | 0.00x |
| 2019 | $2.85 Million | $1.52 Trillion | $2.96 Billion | 0.00x | 0.00x |
| 2020 | $20.18 Million | $1.72 Trillion | $170.96 Billion | 0.00x | 0.00x |
| 2021 | $8.09 Million | $1.84 Trillion | $55.27 Billion | 0.00x | 0.00x |
| 2022 | $5.32 Million | $2.08 Trillion | $32.82 Billion | 0.00x | 0.00x |
| 2023 | $5.09 Million | $2.06 Trillion | -$54.14 Billion | 0.00x | N/A |
| 2024 | $3.86 Million | $2.20 Trillion | $24.03 Billion | 0.00x | 0.00x |
| 2025 | $4.30 Million | $2.45 Trillion | -$69.51 Billion | 0.00x | N/A |
Competitor Companies of 005257 by Market Capitalization
Companies near Green Cross Holdings Preference Shares in the global market cap rankings as of August 3, 2026.
Key companies related to Green Cross Holdings Preference Shares by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #424 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #543 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #563 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $477.10 |
| #424 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $762.63 |
| #543 | Argen-X | BR:ARGX | $49.55 Billion | €745.00 |
| #563 | UCB SA | BR:UCB | $47.34 Billion | €222.90 |
Green Cross Holdings Preference Shares Historical Marketcap From 2015 to 2026
Between 2015 and today, Green Cross Holdings Preference Shares's market cap moved from $3.96 Million to $ 2.29 Million, with a yearly change of -4.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩2.29 Million | -46.60% |
| 2025 | ₩4.30 Million | +11.42% |
| 2024 | ₩3.86 Million | -24.20% |
| 2023 | ₩5.09 Million | -4.40% |
| 2022 | ₩5.32 Million | -34.20% |
| 2021 | ₩8.09 Million | -59.92% |
| 2020 | ₩20.18 Million | +607.67% |
| 2019 | ₩2.85 Million | +12.74% |
| 2018 | ₩2.53 Million | -38.46% |
| 2017 | ₩4.11 Million | +27.73% |
| 2016 | ₩3.22 Million | -18.80% |
| 2015 | ₩3.96 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Green Cross Holdings Preference Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.29 Million USD |
| MoneyControl | $2.29 Million USD |
| MarketWatch | $2.29 Million USD |
| marketcap.company | $2.29 Million USD |
| Reuters | $2.29 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Green Cross Holdings Preference Shares
GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and… Read more